Daniel Brims
Stock Analyst at Lake Street
(0.04)
# 4,813
Out of 5,088 analysts
29
Total ratings
18.3%
Success rate
-33.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Brims
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RZLT Rezolute | Reiterated: Buy | $9 → $12 | $4.12 | +191.26% | 2 | Oct 6, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $89 | $26.86 | +231.35% | 2 | Sep 23, 2026 | |
| KYNB Kyntra Bio | Initiated Coverage: Buy | $41 | $4.65 | +781.72% | 1 | Sep 17, 2026 | |
| SPRB Spruce Biosciences | Initiated Coverage: Buy | $149 | $46.82 | +218.24% | 1 | Sep 17, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $23 | $10.56 | +117.80% | 5 | Sep 10, 2026 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $45 | $5.03 | +794.63% | 3 | Aug 7, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $9 | $0.6054 | +1,386.62% | 1 | May 18, 2026 | |
| LITS Lite Strategy | Reiterated: Buy | $7 | $1.17 | n/a | 7 | Sep 2, 2015 | |
| IMNN Imunon | Reiterated: Buy | $7 | $0.833 | n/a | 6 | Aug 10, 2015 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Buy | n/a | $12.41 | n/a | 1 | Dec 30, 2014 |
Rezolute
Oct 6, 2026
Reiterated: Buy
Price Target: $9 → $12
Current: $4.12
Upside: +191.26%
Viking Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $89
Current: $26.86
Upside: +231.35%
Kyntra Bio
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $41
Current: $4.65
Upside: +781.72%
Spruce Biosciences
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $149
Current: $46.82
Upside: +218.24%
Kura Oncology
Sep 10, 2026
Reiterated: Buy
Price Target: $23
Current: $10.56
Upside: +117.80%
Aligos Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $5.03
Upside: +794.63%
Rani Therapeutics Holdings
May 18, 2026
Reiterated: Buy
Price Target: $9
Current: $0.6054
Upside: +1,386.62%
Lite Strategy
Sep 2, 2015
Reiterated: Buy
Price Target: $7
Current: $1.17
Upside: n/a
Imunon
Aug 10, 2015
Reiterated: Buy
Price Target: $7
Current: $0.833
Upside: n/a
Bausch Health Companies Inc.
Dec 30, 2014
Reiterated: Buy
Price Target: n/a
Current: $12.41
Upside: n/a